Christine Blank
FDA approves non-opioid drug for shoulder surgery
FDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.
FDA approves landmark AI device to detect diabetic eye disease
FDA is permitting marketing of the first medical device that uses artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy.
FDA approves first-of-its kind diabetes management device
FDA okayed the marketing of a new continuous glucose monitoring system for diabetics—the first to be used as part of an integrated system with other compatible medical devices and electronic interfaces.
DTC drug ads don't show risks, study says
As FDA considers new guidelines on pharmaceutical product marketing, a new study found that pharma makers may not be following current FDA ad regulations.
Top 3 novel diabetes treatments
Over the past few months, several new diabetes treatments have been approved by FDA. Here are the top 3 novel drugs for diabetes.
FDA approves breakthrough drug for HIV patients with dwindling options
FDA approves breakthrough drug for HIV patients with dwindling options
A new FDA-approved drug offers new hope for patients with multidrug-resistant HIV-1 infection.
New warning on antibiotic for heart disease patients
New warning on antibiotic for heart disease patients
FDA is advising caution before healthcare professionals prescribe a certain antibiotic to patients with heart disease due to a potential increased risk of heart problems or death that can occur years later.
3 new FDA drug approvals
FDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.
Patient group pushes FDA to improve biosimilar education
FDA should provide better education about biosimilar drugs on the agency’s web site dedicated to biosimilars, a patient advocacy group said.
DEA tightens fentanyl scheduling
Due to the increased use of illicit fentanyl mixed with heroin and used in counterfeit prescription drugs, the DEA placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule I.